Centric Wealth Management Bristol Myers Squibb CO Transaction History

Centric Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $164,582 - $216,676	4,089 New	4,089 $169,000
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $3 Million - $3.27 Million	-48,458 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $2.51 Million - $2.83 Million	42,334 Added 691.28%	48,458 $3.06 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $39,378 - $44,623	682 Added 12.53%	6,124 $380,000
Q3 2020 Oct 05, 2020	SELL	$57.43 - $63.64 $20,387 - $22,592	-355 Reduced 6.12%	5,442 $268,000
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $19,461 - $22,751	355 Added 6.52%	5,797 $341,000
Q1 2020 Apr 08, 2020	SELL	$46.4 - $67.43 $4,964 - $7,215	-107 Reduced 1.93%	5,442 $268,000
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $5,265 - $6,868	107 Added 1.97%	5,549 $356,000
Q3 2019 Oct 03, 2019	BUY	$42.77 - $50.71 $232,754 - $275,963	5,442 New	5,442 $268,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Centric Wealth Management with notifications on news.